Introducere. Sindromul algic pelvin apare mai frecvent la femeile după un puseu de boala inflamatorie pelvină acută. Durerea se asociază frecvent şi cu o dispariunie pronunţată. Scopul lucrării. A fost studiat sindromul algic pelvin dupa un puseu de boala inflamatorie pelvină acută. Material şi metode. Studiul randomizat, simplu, orb. În studiu au fost incluse 234 de paciente care au suferit de un puseu de boală inflamatorie pelvină. Pacientelor li s-a propus să fie consultate şi investigate clinic şi chestionate după un chestionar model. Rezultate. Evaluând sindromul algic pelvin la pacientele din studiul nostru, am constatat că durerea pelvină ciclică s-a prezentat la 73 (62,39±4,48%) vs. 58 (49,57±4,62%) (p<0,05), iar durere pelvină permanentă s-a constatat în 11 (9,4±2,69%) vs. 8 (6,84±2,33%) (p>0,05). Dispariunie a fost la 48 (41,48%) vs. 31 (26,50±4,46%) (p>0,05). Concluzii. Sindromului algic pelvin este complicația frecventă a bolii inflamatorii pelvine, care a fost observată şi în studiul nostru la 2/3 din paciente asociată cu dispariunia.

Introduction. Pelvic algic syndrome occurs more frequently in women with acute pelvic inflammatory disease bout. The pain is associated often and with a pronounced dyspareunia. Objective of the study. pelvic pain syndrome was studied after a relapse of acute pelvic inflammatory disease. Material and methods.The study randomized, simple, blind. The study included 234 patients who suffered from a relapse of pelvic inflammatory disease. Patients were asked to be consulted and interviewed and clinically investigated as a model questionnaire. Results. Evaluating the pelvic pain syndrome in patients of our study, we found that cyclic pelvic pain appeared in 73 (62.39±4.48%) vs. 58 (49.57±4.62%) (p<0.05) and constant pelvic pain was found in 11 (9.4±2.69%) vs. 8 (6.84±2.33%) (p>0.05). Dyspareunia was present in 48 (41.48) vs. 31 (26.50±4.46%) (p>0.05). Conclusions. The pelvic algic syndrome is a common complication of the pelvic inflammatory disease observed in our study in 2/3 of patients associated with dyspareunia.